Both in Pharmaceuticals
Biomea Fusion vs Serina Therapeutics
Over the past year BMEA returned −51.4% and SER returned −60.9%; their daily moves had a correlation of 0.07.
BMEA −51.4% SER −60.9%Growth of $1, one year, split-adjusted
| Metric | BMEA | SER |
|---|---|---|
| Price | $0.6119 | $1.69 |
| Market cap | $44.4M | $42.9M |
| Today | −1.91% | −7.65% |
| 1 month | −51.0% | −17.2% |
| 6 months | −61.8% | −7.7% |
| Year to date | −50.7% | −11.7% |
| 1 year | −53.6% | −63.9% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.8M | $19.9M |
| Dividend yield | — | — |
| Volatility (60d) | 122.0% | 75.8% |
| Short % of float | 24.1% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).